Dr Andreas Alber
Dr. Andreas Alber is a postdoctoral researcher at The Pirbright Institute. He is a trained molecular biologist with a keen interest in translational science. His previous work experiences included both translational and fundamental research projects. He was a postdoctoral researcher supporting a team of scientists and commercial experts at the University of Edinburgh in testing and validating miRNAs as anti-viral therapy for human influenza and respiratory syncytial virus infections. More recently, he was a postdoctoral researcher working on the chicken innate immune system and its response to avian pathogenic Escherichia coli. His current research at The Pirbright Institute focuses on interferon-inducible transmembrane (IFITM) proteins in chickens, which represent an important first-line of defence against viral infections.
He is particularly interested in observations made in the Fife lab, that a reduction in chicken IFITM expression in cells results in an increase in the virus titre of an influenza A virus, suggesting that chicken IFITMs have a functional role in the control of viral infections and that their inhibition may result in increased virus titres after infection. This may have useful implications for animal and human vaccine production as vaccines are produced in cell lines.